Back

Circulating miR-4532 is associated with loss of ambulation in dysferlinopathy

Grewal, T. S.; Hollander, Z.; Dai, D. L.; Chen, V.; Windish, H. P.; Albrecht, D. E.; Paoliello, E. L.; Rufibach, L.; Williams, B.; Mittal, P.; Assadian, S.; Wilson-McManus, J. E.; McManus, B.; Ng, R.; Tebbutt, S.; Bernatchez, P.; Singh, A.

2026-01-06 bioinformatics
10.64898/2026.01.05.697793 bioRxiv
Show abstract

BackgroundLimb-girdle muscular dystrophies (LGMDs) are inherited myopathies characterized mainly by progressive weakness of the proximal muscles of the shoulder and pelvic girdle areas, leading to functional decline and eventual loss of independent ambulation. Dysferlinopathy (LGMD2B) is an autosomal recessive LGMD subtype, is caused by mutations in the DYSF gene that lead to lack of dysferlin which results in muscle death and chronic muscle fiber degeneration. Preservation of ambulation is a key clinical milestone, as loss of independent gait markedly reduces quality of life and complicates care management. Although patients often perceive functional decline before their initial clinical presentation, current clinical assessments typically detect disease progression after substantial muscle damage has occurred. MethodsIn this multigroup case-control study, we profiled plasma miRNAs from 49 genetically confirmed dysferlinopathy patients (24 ambulatory, 25 non-ambulatory) and 25 age- and sex-matched healthy controls. Total RNA was extracted from blood samples and hybridized to Affymetrix GeneChip miRNA 3.1 arrays. After quality control and filtering, differential expression analysis was performed using linear models for microarrays, adjusting for age and sex, with a false discovery rate cutoff of 10%. Results14 miRNAs were significantly altered between dysferlinopathy patients and controls. Notably, miR-4532 was upregulated in ambulatory patients relative to controls, whereas it was downregulated in non-ambulatory patients compared with ambulatory patients, although expression levels remained higher than in controls. Levels of miR-4532 were positively associated with circulating monocyte levels in ambulatory patients only. ConclusionThese results suggest that miR-4532 may be a circulating marker associated with ambulatory status in dysferlinopathy. Its known involvement in inflammatory signaling and muscle regeneration pathways underscores its potential as an early indicator for disease activity.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

1
Journal of Cachexia, Sarcopenia and Muscle
27 papers in training set
Top 0.1%
35.6%
2
PLOS ONE
4510 papers in training set
Top 26%
6.6%
3
Scientific Reports
3102 papers in training set
Top 26%
4.5%
4
Annals of Clinical and Translational Neurology
29 papers in training set
Top 0.3%
3.2%
5
Human Molecular Genetics
130 papers in training set
Top 0.9%
3.2%
50% of probability mass above
6
Differentiation
11 papers in training set
Top 0.1%
2.8%
7
Acta Neuropathologica Communications
81 papers in training set
Top 0.3%
2.8%
8
International Journal of Molecular Sciences
453 papers in training set
Top 5%
2.2%
9
Neurobiology of Disease
134 papers in training set
Top 2%
2.0%
10
Trials
25 papers in training set
Top 0.9%
1.5%
11
Frontiers in Physiology
93 papers in training set
Top 3%
1.4%
12
Molecular Therapy - Nucleic Acids
24 papers in training set
Top 0.2%
1.3%
13
Muscle & Nerve
10 papers in training set
Top 0.2%
1.3%
14
Disease Models & Mechanisms
119 papers in training set
Top 2%
1.3%
15
PeerJ
261 papers in training set
Top 11%
1.1%
16
Frontiers in Neurology
91 papers in training set
Top 4%
1.0%
17
Frontiers in Immunology
586 papers in training set
Top 6%
1.0%
18
BMC Methods
11 papers in training set
Top 0.1%
0.9%
19
Gigabyte
60 papers in training set
Top 1%
0.9%
20
Orphanet Journal of Rare Diseases
18 papers in training set
Top 0.5%
0.9%
21
Human Mutation
29 papers in training set
Top 0.6%
0.8%
22
Annals of the Rheumatic Diseases
32 papers in training set
Top 0.6%
0.8%
23
JCI Insight
241 papers in training set
Top 7%
0.8%
24
Neurology
44 papers in training set
Top 1%
0.8%
25
Neuropathology and Applied Neurobiology
14 papers in training set
Top 0.6%
0.8%
26
NAR Molecular Medicine
18 papers in training set
Top 0.2%
0.7%
27
The FASEB Journal
175 papers in training set
Top 3%
0.7%
28
eLife
5422 papers in training set
Top 58%
0.7%
29
Rheumatology
21 papers in training set
Top 0.4%
0.7%
30
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
25 papers in training set
Top 1%
0.7%